(Q33499399)

English

Idarubicin and intermediate dose ARA-C followed by consolidation chemotherapy or bone marrow transplantation in relapsed or refractory acute myeloid leukemia

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Idarubicin and intermediate dose ARA-C followed by consolidation chemotherapy or bone marrow transplantation in relapsed or refractory acute myeloid leukemia (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

1 reference

based on heuristic

inferred from title

acute myeloid leukemia

1 reference

based on heuristic

inferred from title

author name string

De La Serna J

1

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Francisco Tomás J

2

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Solano C

3

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

García de Paredes ML

4

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Campbell J

5

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Grande C

6

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Diaz-Mediavilla J

7

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

publication date

1 April 1997

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Leukemia & Lymphoma

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

3-4

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

365-372

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Some reasons for the lack of progress in the treatment of acute myelogenous leukemia: a review of three consecutive trials of the treatment of poor prognosis patients

1 reference

https://api.crossref.org/works/10.3109%2F10428199709114175

21 January 2018

Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B

1 reference

https://api.crossref.org/works/10.3109%2F10428199709114175

21 January 2018

Treatment of resistant acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428199709114175

21 January 2018

Role of interleukin-1 inhibitory molecules in therapy of acute and chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428199709114175

21 January 2018

Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group

1 reference

https://api.crossref.org/works/10.3109%2F10428199709114175

21 January 2018

Management of patients with acute non-lymphocytic leukemia who fail first cycle of induction therapy

1 reference

https://api.crossref.org/works/10.3109%2F10428199709114175

21 January 2018

Identifiers

10.3109/10428199709114175

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33499399&oldid=1534947425"